| 1 | Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting. (Zhang Z, Rodriguez M, Zheng Z) Arterioscler Thromb Vasc Biol 2024 Mar;44(3):533-544 2 Citations |
| 2 | Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage. (Cicci CD, Weiss A, Dang C, Stanton M, Feldman R) Pharmacotherapy 2022 May;42(5):366-374 5 Citations |
| 1 | Electronic clinical decision support to facilitate a change in clinical practice: Small details can make or break success. (Connor JP, Medow JE, Ehlenfeldt BD, Rose AE, Raife T) Transfusion 2020 Sep;60(9):1970-1976 4 Citations |
| 1 | Indications and Methods of Anticoagulation Reversal. (Holzmacher JL, Sarani B) Surg Clin North Am 2017 Dec;97(6):1291-1305 9 Citations |
| 1 | Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. (Kastelowitz N, Tamura R, Onasoga A, Stalker TJ, White OR, Brown PN, Brodsky GL, Brass LF, Branchford BR, Di Paola J, Yin H) Sci Rep 2017 Jun 27;7(1):4275 14 Citations |
| 1 | EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. (Liang HP, Kerschen EJ, Hernandez I, Basu S, Zogg M, Botros F, Jia S, Hessner MJ, Griffin JH, Ruf W, Weiler H) Blood 2015 Apr 30;125(18):2845-54 69 Citations |
| 1 | Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates. (Baumann Kreuziger LM, Keenan JC, Morton CT, Dries DJ) Biomed Res Int 2014;2014:583794 43 Citations |
| 1 | Platelet and endothelial expression of clotting factors for the treatment of hemophilia. (Montgomery RR, Shi Q) Thromb Res 2012 May;129 Suppl 2(Suppl 2):S46-8 16 Citations |
| 1 | Alternative strategies for gene therapy of hemophilia. (Montgomery RR, Shi Q) Hematology Am Soc Hematol Educ Program 2010;2010:197-202 5 Citations |
| 1 | Corneal activation of prothrombin to form thrombin, independent of vascular injury. (Ayala A, Warejcka DJ, Olague-Marchan M, Twining SS) Invest Ophthalmol Vis Sci 2007 Jan;48(1):134-43 14 Citations |
| 2 | Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. (Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H) Blood 2006 Apr 15;107(8):3173-80 89 Citations |
| 1 | Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs? (White GC 2nd, Kempton CL, Grimsley A, Nielsen B, Roberts HR) J Thromb Haemost 2005 Aug;3(8):1676-81 74 Citations |
| 1 | Thrombophilia and pregnancy failure: feto-maternal interactions in the vascular bed of the placenta. (Sood R, Kalloway S, Mast AE, Weiler H) Thromb Res 2005 Feb;115 Suppl 1:92-4 2 Citations |
| 1 | The partial thromboplastin time: defining an era in coagulation. (White GC 2nd) J Thromb Haemost 2003 Nov;1(11):2267-70 62 Citations |
| 1 | Embryogenesis and gene targeting of coagulation factors in mice. (Sood R, Weiler H) Best Pract Res Clin Haematol 2003 Jun;16(2):169-81 6 Citations |
| 1 | Seventeen years' experience with Autoplex/Autoplex T: evaluation of inpatients with severe haemophilia A and factor VIII inhibitors at a major haemophilia centre. (White GC 2nd) Haemophilia 2000 Sep;6(5):508-12 14 Citations |
| 1 | Mammalian recombinant coagulation proteins: structure and function. (White GC 2nd, Pickens EM, Liles DK, Roberts HR) Transfus Sci 1998 Jun;19(2):177-89 14 Citations |
| 1 | Treatment of the hemophilias. (Moll S, White GC 2nd) Curr Opin Hematol 1995 Sep;2(5):386-94 2 Citations |
| 1 | Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B. (Kim HC, McMillan CW, White GC, Bergman GE, Saidi P) Semin Hematol 1990 Apr;27(2 Suppl 2):30-5 24 Citations |
© 2025 Clinical & Translational Science Institute